Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06636539 · ClinicalTrials.gov registry record · NA
Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device
A NA study of Breast Screening, sponsored by Hologic.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 2
- Study locations
NCT06636539: Recruiting NA study of Breast Screening, sponsored by Hologic.
NCT06636539 is a NA study of Breast Screening that is actively recruiting participants, run by Hologic. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06636539, a NA study of Breast Screening, is actively recruiting participants, sponsored by Hologic.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective, multi-center image case collection study to acquire de-identified contrast-enhanced breast images on a mammography device to support continuing software technology development. Eligible subjects include women at least 35 years old with a suspicious finding or breast abnormality on a screening or diagnostic mammogram who are indicated for a diagnostic exam or a biopsy procedure.
Primary Outcome
Number of subjects with contrast-enhanced breast images containing lesions as assessed by radiologists' image quality review
Conditions Studied
Interventions
- DEVICE CEM Software in New Mammography Device
Study Locations (2)
Texas
- Solis Mammography Memorial Village - Houston
Virginia
- Washington Radiology Sterling - Sterling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2024-10-14 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What NCT06636539 shows while recruiting
NCT06636539 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Breast Screening appearing as the primary indexed condition, and to 1 intervention - of which CEM Software in New Mammography Device is the first listed.
NCT06636539 reports a single indexed study location in Texas, Virginia.
Frequently Asked Questions
What is clinical trial NCT06636539 about?
NCT06636539 is a clinical study titled "Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device". This is a prospective, multi-center image case collection study to acquire de-identified contrast-enhanced breast images on a mammography device to support continuing software technology development. Eligible subjects include women at least 35 years old with a suspicious finding or breast abnormalit...
What is the current status of trial NCT06636539?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2024-10-14. Estimated completion is 2026-03-31.
What conditions does trial NCT06636539 study?
This clinical trial studies the following conditions: Breast Screening.
What interventions are being tested in trial NCT06636539?
The interventions under investigation include: CEM Software in New Mammography Device (DEVICE).
Who is sponsoring clinical trial NCT06636539?
This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06636539 being conducted?
This trial has 2 study locations across Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06636539's enrollment target sits among peer trials
75 1069th of 2000 higher than 919 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI